Table 3.

The prevalence and genotype distribution and of HPV according to age.

	Age groups (years)
	≤29 (%)	30–39 (%)	40–49 (%)	50–59 (%)	≥60 (%)
HPV	(n = 86)	(n = 227)	(n = 290)	(n = 243)	(n = 94)
Any HPV	73 (84.88)	192 (84.58)	245 (84.48)	198 (81.48)	80 (85.11)
HR-HPV	71 (82.56)	186 (81.94)	238 (82.07)	194 (79.84)	80 (85.11)
16	29 (33.72)	75 (33.04)	93 (32.07)	93 (38.27)	45 (47.87)
18	11 (12.79)	22 (9.69)	18 (6.21)	17 (7.00)	7 (7.45)
31	2 (2.33)	24 (10.57)	13 (4.48)	11 (4.53)	4 (4.26)
33	3 (3.49)	20 (8.81)	24 (8.28)	28 (11.52)	9 (9.57)
35	1 (1.16)	3 (1.32)	9 (3.10)	9 (3.70)	6 (6.38)
39	4 (4.65)	2 (0.88)	7 (2.41)	2 (0.82)	0 (0.00)
45	0 (0.00)	2 (0.88)	0 (0.00)	5 (2.06)	0 (0.00)
51	11 (12.79)	15 (6.61)	14 (4.83)	8 (3.29)	5 (5.32)
52	11 (12.79)	34 (14.98)	58 (20.00)	38 (15.64)	18 (19.15)
53	12 (13.95)	17 (7.49)	25 (8.62)	17 (7.00)	2 (2.13)
56	6 (6.98)	20 (8.81)	15 (5.17)	16 (6.58)	9 (9.57)
58	7 (8.14)	26 (11.45)	49 (16.90)	36 (14.81)	13 (13.83)
59	6 (6.98)	3 (1.32)	9 (3.10)	6 (2.47)	1 (1.06)
66	3 (3.49)	8 (3.52)	7 (2.41)	8 (3.29)	1 (1.06)
68	7 (8.14)	8 (3.52)	20 (6.90)	14 (5.76)	5 (5.32)
73	2 (2.33)	0 (0.00)	1 (0.34)	3 (1.23)	1 (1.06)
82	1 (1.16)	0 (0.00)	0 (0.00)	0 (0.00)	0 (0.00)
LR-HPV	13 (15.12)	25 (11.01)	39 (13.45)	30 (12.35)	7 (7.45)
6	6 (6.98)	3 (1.32)	10 (3.45)	8 (3.29)	0 (0.00)
11	1 (1.16)	1 (0.44)	0 (0.00)	4 (1.65)	0 (0.00)
42	3 (3.49)	1 (0.44)	7 (2.41)	5 (2.06)	3 (3.19)
43	2 (2.33)	7 (3.08)	9 (3.10)	7 (2.88)	2 (2.13)
81	2 (2.33)	13 (5.73)	15 (5.17)	8 (3.29)	4 (4.26)
83	0 (0.00)	0 (0.00)	0 (0.00)	1 (0.41)	1 (1.06)